Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | News
Search Refinements

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
121-135 of 4402 results
TransThera raises $10m financing to develop Novel NCE Drugs
Biotech startup TransThera Biosciences has raised Round A Financing close to $10m from a group of investors, led by Morningside Ventures.
Drug Research > Drug Discovery & Development > News
AMAG Pharmaceuticals achieves key milestones in next generation development programs
AMAG Pharmaceuticals has achieved two key milestones in its next generation development programs for Makena and Feraheme.
Drug Research > Drug Discovery & Development > News
RXi Pharmaceuticals signs option deal to buy MirImmune
By PBR Staff Writer
RXi Pharmaceuticals has signed an option agreement to acquire MirImmune, a privately held biopharmaceutical firm engaged in the development of new generation immunotherapies for cancer.
Drug Research > Drug Discovery & Development > News
Metabrain Research and Medicxi establish Kymo Therapeutics
Metabrain Research has signed an agreement with Medicxi, an European life sciences venture capital firm, for the inception of Kymo Therapeutics, incorporated in Cambridge (UK).
Drug Research > Drug Discovery & Development > News
Alnylam scraps RNAi drug development over safety concerns
By PBR Staff Writer
Alnylam Pharmaceuticals is stopping the development of revusiran, a therapeutic intended at treating hereditary ATTR amyloidosis with cardiomyopathy (hATTR-CM), due to safety concerns.
Drug Research > Drug Discovery & Development > News
Japanese cell biologist Yoshinori Ohsumi wins Nobel Prize in medicine
By PBR Staff Writer
Japanese cell biologist Yoshinori Ohsumi has been awarded the 2016 Nobel Prize in physiology or medicine, for his discoveries of mechanisms for autophagy.
Drug Research > Drug Discovery & Development > News
Recursion Pharmaceuticals raises $12.9m to apply AI to drug discovery
Recursion Pharmaceuticals has raised $12.9m to discover new drugs using artificial intelligence (AI).
Drug Research > Drug Discovery & Development > News
Amgen, Arrowhead to develop gene therapies for cardiovascular disease
By PBR Staff Writer
Amgen said it will acquire a stake in Arrowhead Pharmaceuticals and partner with the company in the development of gene therapies for cardiovascular disease.
Drug Research > Drug Discovery & Development > News
Boehringer, ViraTherapeutics partner to jointly develop oncolytic virus therapy platform
Boehringer Ingelheim and ViraTherapeutics are collaborating to jointly develop a next generation oncolytic virus therapy platform and to investigate ViraTherapeutics’ lead candidate VSV-GP (Vesicular Stomatitis Virus (VSV) glycoprotein (GP)) alone and in combination with other therapies.
Drug Research > Drug Discovery & Development > News
Pfizer closes Medivation acquisition
Pfizer has completed its acquisition of US biopharmaceutical firm Medivation for about $14bn.
Drug Research > Drug Discovery & Development > News
Redx Pharma discovers breakthrough antibiotic compounds
Redx Pharma has discovered a series of compounds that have the potential to create the first novel class of broad-spectrum antibiotics in 30 years.
Drug Research > Drug Discovery & Development > News
C4X Discovery enters into multi-target, risk-sharing alliance with Evotec
C4X Discovery has entered into a multi-target, risk-sharing alliance (the agreement) with Evotec, a drug discovery alliance and development partnership firm.
Drug Research > Drug Discovery & Development > News
Sanofi secures $43m US funding to spur Zika vaccine development
The Biomedical Advanced Research and Development Authority (BARDA) within the Office of the Assistant Secretary for Preparedness and Response in the US Department of Health and Human Services is giving Sanofi $43.2m to fund the manufacture of a Zika vaccine for phase II development.
Drug Research > Drug Discovery & Development > News
Turing advances several experimental compounds into pre-clinical development
Turing Pharmaceuticals has advanced several experimental compounds into pre-clinical development.
Drug Research > Drug Discovery & Development > News
Allergan to acquire Tobira Therapeutics in $1.7bn deal
By PBR Staff Writer
Allergan has agreed to acquire clinical-stage biopharmaceutical firm Tobira Therapeutics in a deal worth about $1.7bn.
Drug Research > Drug Discovery & Development > News
121-135 of 4402 results